Dudediligence.

Apogee Therapeutics, Inc

APGENASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 38-KAcquisition or sale of assets completed and officer or director change1.022.013.013.035.015.025.039.01
  2. Aug 118-KOfficer or director change and shareholder vote5.025.07
  3. Aug 1010-QQuarterly report
  4. Aug 108-KResults of operations2.029.01
  5. Jun 228-KMaterial agreement and Regulation FD disclosure1.015.077.018.019.01
  6. Jun 228-KMaterial agreement1.019.01
  7. Jun 128-KShareholder vote5.07
  8. May 278-KMaterial agreement and Regulation FD disclosure1.017.019.01
  9. May 278-KRegulation FD disclosure and other events7.018.019.01
  10. May 1110-QQuarterly report
  11. May 118-KResults of operations2.029.01
  12. Apr 248-KOfficer or director change5.02
  13. Mar 258-KMaterial agreement1.019.01
  14. Mar 25424B5Prospectus for an offering
  15. Mar 23424B5Prospectus for an offering
  16. Mar 238-KRegulation FD disclosure and other events7.018.019.01
  17. Mar 210-KAnnual report
  18. Mar 28-KFinancial statements and exhibits9.01
  19. Jan 68-KRegulation FD disclosure and other events7.018.019.01
  20. Nov 10, 202510-QQuarterly report
  21. Nov 10, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  22. Oct 10, 20258-KMaterial agreement and other events1.018.019.01
  23. Oct 10, 2025424B5Prospectus for an offering
  24. Oct 8, 2025424B5Prospectus for an offering
  25. Aug 11, 202510-QQuarterly report
  26. Aug 11, 20258-KResults of operations2.029.01